US Patent 8221760 Methods of treatment using human anti-IL-23 antibodies
Patent 8221760 was granted and assigned to Janssen Biotech on July, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 30, 2011
0
Date of Patent
July 17, 2012
0
Patent Application Number
13173090
0
Patent Citations Received
Patent Inventor Names
Jill Carton
0
Jacqueline Benson
0
Mark Cunningham
0
Raymond Sweet
0
Robert Rauchenberger
0
Yevgeniya I. Orlovsky
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8221760 Methods of treatment using human anti-IL-23 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.